Ovalbumin lipid core peptide vaccines and their CD4+ and CD8+ T cell responses
Ovalbumin lipid core peptide vaccines and their CD4+ and CD8+ T cell responses
About this item
Full title
Author / Creator
Publisher
Kidlington: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Abstract The lipid core peptide (LCP) system has successfully been used in development of peptide-based vaccines against cancer and infectious diseases (such as group A streptococcal infection). CD8+ T cells are important targets for vaccines, however developing a vaccine that activates long-lasting immunity has proven challenging. The ability of L...
Alternative Titles
Full title
Ovalbumin lipid core peptide vaccines and their CD4+ and CD8+ T cell responses
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1554952464
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1554952464
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2014.06.049
